Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Maeva Guillaume"'
Autor:
Romain Itier, Maeva Guillaume, Jean‐Etienne Ricci, François Roubille, Nicolas Delarche, François Picard, Michel Galinier, Jérôme Roncalli
Publikováno v:
ESC Heart Failure, Vol 8, Iss 2, Pp 789-798 (2021)
Abstract The prevalence of non‐alcoholic fatty liver disease (NAFLD) in heart failure (HF) preserved left ventricular ejection fraction (HFpEF) patients could reach 50%. Therefore, NAFLD is considered an emerging risk factor. In 20% of NAFLD patien
Externí odkaz:
https://doaj.org/article/28e2cbf3e8e54e5d8d950fbb41a5b02d
Autor:
Maeva Guillaume, Elodie Riant, Aurélie Fabre, Isabelle Raymond‐Letron, Melissa Buscato, Morgane Davezac, Blandine Tramunt, Alexandra Montagner, Sarra Smati, Rana Zahreddine, Gaëlle Palierne, Marie‐Cécile Valera, Hervé Guillou, Françoise Lenfant, Klaus Unsicker, Raphaël Metivier, Coralie Fontaine, Jean‐François Arnal, Pierre Gourdy
Publikováno v:
Hepatology Communications, Vol 3, Iss 7, Pp 908-924 (2019)
Hepatocyte estrogen receptor α (ERα) was recently recognized as a relevant molecular target for nonalcoholic fatty liver disease (NAFLD) prevention. The present study defined to what extent hepatocyte ERα could be involved in preserving metabolic
Externí odkaz:
https://doaj.org/article/abefe13400694a3ab2acdc1d9aad812d
Autor:
Pierre Gourdy, Maeva Guillaume, Coralie Fontaine, Marine Adlanmerini, Alexandra Montagner, Henrik Laurell, Françoise Lenfant, Jean-François Arnal
Publikováno v:
Molecular Metabolism, Vol 15, Iss , Pp 56-69 (2018)
Background: In addition to their crucial role in reproduction, estrogens are key regulators of energy and glucose homeostasis and they also exert several cardiovascular protective effects. These beneficial actions are mainly mediated by estrogen rece
Externí odkaz:
https://doaj.org/article/096e3e76aa6741b4bf8d9841ec288204
Autor:
Marie-Cécile Valéra, Emmanuelle Noirrit-Esclassan, Marion Dupuis, Melissa Buscato, Alexia Vinel, Maeva Guillaume, Anne Briaux, Cédric Garcia, Thibaut Benoit, Olivier Lairez, Coralie Fontaine, Bernard Payrastre, Jean-François Arnal
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0177043 (2017)
Postmenopausal hormone replacement therapy (HRT) with estrogen plus progestogens is the first line therapy to treat menopausal symptoms. The progestogen is added to estrogen to reduce or eliminate the excess risk of endometrial cancer due to the unop
Externí odkaz:
https://doaj.org/article/b356b8c96b1e47b1a003381fa7aadf85
Autor:
Jacob George, Philip Newsome, Henning Grønbæk, Manuel Romero-Gómez, Syed-Mohammed Jafri, Lynsey Corless, Joanna Uddén Hemmingsson, Rodolphe Anty, Jude Oben, Vlad Ratziu, Maeva Guillaume
Publikováno v:
Newsome, P N, Buchholtz, K, Cusi, K, Linder, M, Okanoue, T, Ratziu, V, Sanyal, A J, Sejling, A-S, Harrison, S A & NN9931-4296 Investigators 2021, ' A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis ', The New England Journal of Medicine, vol. 384, no. 12, pp. 1113-1124 . https://doi.org/10.1056/NEJMoa2028395
BACKGROUND: Nonalcoholic steatohepatitis (NASH) is a common disease that is associated with increased morbidity and mortality, but treatment options are limited. The efficacy and safety of the glucagon-like peptide-1 receptor agonist semaglutide in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cee5c2fb724a8dcdcd7dc228bf819a3
https://doi.org/10.1056/nejmoa2028395
https://doi.org/10.1056/nejmoa2028395
Autor:
Sarra Smatti, Victor de Lédinghen, Bertrand Cariou, Maeva Guillaume, Charlotte Bouzbib, M. Bourlière, Nathalie Ganne-Carrié, Christophe Bureau, Raluca Pais, Adrien Lannes, Jérôme Boursier
Publikováno v:
Clinics and Research in Hepatology and Gastroenterology
Clinics and Research in Hepatology and Gastroenterology, 2022, 46 (1), pp.101769. ⟨10.1016/j.clinre.2021.101769⟩
Clinics and Research in Hepatology and Gastroenterology, 2022, 46 (1), pp.101769. ⟨10.1016/j.clinre.2021.101769⟩
International audience; NAFLD is a frequent disease that affects 25% of the worldwide population. There is no specific diagnostic test for NAFLD, and the diagnosis mainly relies on the elimination of the other causes of chronic liver diseases with li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68be37c4829f1c82f9d61870f6764cad
https://www.hal.inserm.fr/inserm-03651877
https://www.hal.inserm.fr/inserm-03651877
Autor:
Isabelle Ollivier-Hourmand, Manon Allaire, Jean Paul Cervoni, Delphine Weil, Violaine Ozenne, Pierre Emmanuel Rautou, Charlotte Bouzbib, Sabrina Sidali, Frédéric Oberti, Maeva Guillaume, Paul Castellani, Paul Calame, Sandrine Barge, Christophe Bureau
Publikováno v:
Journal of Hepatology. 77:566-567
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fabbd221cd294220dd4cba7e6872096c
https://doi.org/10.1016/j.jhep.2022.02.004
https://doi.org/10.1016/j.jhep.2022.02.004
Autor:
Afef, Sfd, Anne Minello, Niasha Michot, Jean-Michel Petit, Bertrand Cariou, Armand Garioud, Maeva Guillaume, Jérôme Boursier, Laurent Castera, Claire Carette, Pierre Gourdy, Bruno Vergès, Fabrice Bonnet, Lawrence Serfaty, Dann Joseph Ouizeman, Rodolphe Anty, Hélène Fontaine, Cyrielle Caussy, Bruno Guerci
Publikováno v:
Diabetes and Metabolism
Diabetes and Metabolism, Elsevier Masson, 2021, 47 (5), pp.101272. ⟨10.1016/j.diabet.2021.101272⟩
Diabetes & Metabolism
Diabetes & Metabolism, 2021, 47 (5), pp.101272. ⟨10.1016/j.diabet.2021.101272⟩
Endocrinology, Diabetes & Metabolism
Endocrinology, Diabetes & Metabolism, Wiley, 2021, 47 (5), pp.101272. ⟨10.1016/j.diabet.2021.101272⟩
Diabetes and Metabolism, Elsevier Masson, 2021, 47 (5), pp.101272. ⟨10.1016/j.diabet.2021.101272⟩
Diabetes & Metabolism
Diabetes & Metabolism, 2021, 47 (5), pp.101272. ⟨10.1016/j.diabet.2021.101272⟩
Endocrinology, Diabetes & Metabolism
Endocrinology, Diabetes & Metabolism, Wiley, 2021, 47 (5), pp.101272. ⟨10.1016/j.diabet.2021.101272⟩
International audience; Type 2 diabetes mellitus (T2DM) is a frequent comorbidity in patients with cirrhosis that is projected to rise in prevalence due to the worldwide burden of obesity, insulin-resistance and non-alcoholic fatty liver disease. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64e43e676e675de17412e9279a3b8a75
https://hal.archives-ouvertes.fr/hal-03336710
https://hal.archives-ouvertes.fr/hal-03336710
Autor:
Adrien Lannes, Floraine Zuberbuhler, Sophie Michalak, Pierre Gourdy, Isabelle Fouchard-Hubert, Janick Selves, Maeva Guillaume, S. Metivier, Jean-Marie Peron, Jérôme Boursier, Christophe Bureau, Marie-Angèle Robic, Frédéric Oberti, Cyrielle Delabaudière, Valérie Moal, Paul Calès
Publikováno v:
Alimentary Pharmacology & Therapeutics. 50:1214-1222
BACKGROUND The Enhanced Liver Fibrosis score (ELF) and the FibroMeterV2G are two specialized blood fibrosis tests which include direct markers of liver fibrosis. They have been shown to be more accurate than the simple blood fibrosis tests FIB4 and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f9e89f0be081a144aa2a17a53171427
https://doi.org/10.1111/apt.15529
https://doi.org/10.1111/apt.15529
Autor:
Jean-Pierre Vinel, Lucile Moga, Maeva Guillaume, Marie-Angèle Robic, Pauline Cabarrou, Hélène Blasco-Perrin, Julie Mogno, Jean-Marie Peron, Christophe Bureau
Publikováno v:
Clinics and research in hepatology and gastroenterology. 46(4)
Acute kidney injury (AKI) is common in patients with cirrhosis. In 2015, the International Club of Ascites (ICA) proposed new definitions of AKI in order to improve the prediction of outcomes. Our aim was to assess the prevalence and prognostic value
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c9f006963139900d34ab910fa05924d
https://pubmed.ncbi.nlm.nih.gov/34718200
https://pubmed.ncbi.nlm.nih.gov/34718200